Restelli, Umberto, Alfredo Alberti, Adriano Lazzarin, Marzia Bonfanti, Carmela Nappi, and Davide Croce. 2016. “Budget Impact Analysis of the Use of Daclatasvir in Italy for the Treatment of Hepatitis C Virus (HCV) Genotype 3 Patients”. Farmeconomia. Health Economics and Therapeutic Pathways 17 (1):7-12. https://doi.org/10.7175/fe.v17i1.1225.